7.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Avita Medical Inc Borsa (RCEL) Ultime notizie
6 Analysts Assess AVITA Medical: What You Need To Know - Benzinga
AVITA Medical Inc Announces U.S. Commercial Launch Of Cohealyx - MarketScreener
Avita Medical's Cohealyx Wound Treatment Makes Commercial Launch in US; Shares Down 4% - MarketScreener
AVITA Medical Launches Wound Care Product Cohealyx in US - MarketScreener
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - The Manila Times
AVITA Medical launches Cohealyx in the U.S. market - Investing.com
Game-Changing Wound Care: AVITA's New Cohealyx Shows Superior Healing Results - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Sees Large Growth in Short Interest - MarketBeat
Long Term Trading Analysis for (RCEL) - news.stocktradersdaily.com
Does Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect? - MSN
AVITA Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Investors overly negative on undervalued ASX share - Morningstar.com.au
Global healthcare stocks for your watchlist - Morningstar Australia
AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com
AVITA Medical signs manufacturing deal with Stedical Scientific for PermeaDerm - MSN
AVITA Medical (NASDAQ:RCEL) Receives “Buy” Rating from D. Boral Capital - Defense World
What Analysts Are Saying About AVITA Medical Stock - Benzinga
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific - The Manila Times
AVITA Secures Manufacturing, Amends Distribution Agreement with US-Based Healthcare Tech Provider; Shares Rise 7% - Marketscreener.com
AVITA Medical (ASX:AVH) Announces New Manufacturing and Distribution Agreements - The Capital Club
Avita Medical Boosts Production with New Agreement - TipRanks
AVITA Medical Boosts Revenue Share to 60% in Strategic PermeaDerm Deal - Stock Titan
(RCEL) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Skin Burns Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Drugs Market, Prevalence, Medication, Statistics, Therapies, Companies by DelveInsight - The Globe and Mail
Investors Don't See Light At End Of AVITA Medical, Inc.'s (NASDAQ:RCEL) Tunnel - Simply Wall St
How To Trade (RCEL) - Stock Traders Daily
Avita Medical LimitedADR to Host Earnings Call - ACCESS Newswire
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference - The Manila Times
Can AVITA Medical's Conference Appearance Signal New Growth Opportunities in Wound Care? - StockTitan
Burns Pipeline 2024: Therapies, MOA Insights, and Key Clinical - openPR
D. Boral Capital Lowers AVITA Medical (NASDAQ:RCEL) Price Target to $22.00 - MarketBeat
AVITA Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Insider Buying: Robert Mcnamara Acquires 10,000 Shares of AVITA Medical Inc (RCEL) - GuruFocus.com
Insider Buying: AVITA Medical, Inc. (NASDAQ:RCEL) Director Acquires 10,000 Shares of Stock - MarketBeat
Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know - MSN
Avita medical CFO David O'Toole acquires $9,900 in common stock - Investing.com Australia
Avita Medical director Robert McNamara purchases $100,900 in stock By Investing.com - Investing.com South Africa
Avita medical CFO David O’Toole acquires $9,900 in common stock - Investing.com India
AVITA Medical, Inc. (NASDAQ:RCEL) CFO Purchases $10,250.00 in Stock - MarketBeat
Avita Medical director Robert McNamara purchases $100,900 in stock - Investing.com India
Avita medical CFO David O'Toole acquires $9,900 in common stock By Investing.com - Investing.com South Africa
AVITA Medical, Inc. (RCEL): A Bull Case Theory - Insider Monkey
When (RCEL) Moves Investors should Listen - Stock Traders Daily
D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - MarketBeat
After Sales Rebound In January, AVITA Is Set Up For A Monster Year - Seeking Alpha
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):